News

Could you be better off steering clear of the SpaceX IPO, or is this one reason good enough to buy?

AT&T (NYSE:T) announced an expanded client collaboration with Wiliot to deploy its Physical AI platform across large supply chains. The company renewed its partnership with Adaptive ML, with plans to double its use of the AI and machine learning platform for fraud detection and customer engagement. AT&T also entered a commercial collaboration with Derq to bring real time AI roadway safety intelligence into its Intelligent Transportation Platform. AT&T, trading at $23.21, is using these...

Peter Boockvar, Chief Investment Officer at One Point BFG Wealth Partners, told CNBC on June 10 that the technical setup under the AI trade has gotten silly. “Stocks in the AI trade got so far above their moving averages that you just knew that usually chart patterns like that are unsustainable,” he said. His call ... Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

US stock futures tumbled amid reports that the US struck Iran hours after President Trump had pledged to do so, saying negotiations were taking "too long."

Telesat (TSAT) stock has drawn attention after a sharp move over the past year, with the price now at $43.89 and returns ranging from down 20.1% over the past month to up 405.1% over 3 years. See our latest analysis for Telesat. Recent trading has cooled after a strong run, with the share price down 20.1% over the past month but still showing a 50.5% year to date share price return and a 3 year total shareholder return above 4x. If Telesat’s move has you looking more broadly at the space and...

A mega-IPO is about to land in a market already running hot, and one Wall Street strategist sees it as the catalyst that forces investors to broaden their bets. Carol Schleif, Chief Market Strategist at BMO Wealth Management, told CNBC this week that the SpaceX IPO on Friday will pull capital out of the year’s ... Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Anterix (ATEX) delivered earnings and revenue surprises of +26.79% and +23.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

This global container shipping provider, known for flexible logistics solutions, reported a notable insider sale in its latest SEC filing.

A number of stocks jumped in the afternoon session after the U.S. launched "self-defense strikes" on Iran as Trump warned the country "will have to pay the price" for stalling negotiations.

You can't spell SpaceX without "space," but the company could be shifting its focus to another hot tech trend.

The tech giant's stock sold off after a poorly received earnings report.

Adding exposure to dividend stocks can be a great way to boost portfolio diversification.

Investors may be having second thoughts about Caterpillar’s part in the AI data-center construction boom as a supplier of power generators. For Caterpillar, it’s the biggest drop in more than a year, when shares declined 5.78% on April 4, 2025. Shares are down four of the last five trading sessions and off since the start of June, according to Dow Jones Market Data.

The quantum computing entry point today echoes Nvidia before its 2019 surge. From speculative bets like IonQ to safer plays like IBM and Alphabet, here's how to buy the boom.

Quantinuum's public debut didn't attract much attention.

Navan stock surges after the AI-focused corporate travel company surpassed Wall Street’s expectations with first-quarter earnings and raised guidance.

Investing.com -- Oracle has been awarded a contract to provide a cloud-based human resources platform for the U.S. government, the U.S. Office of Personnel Management announced Wednesday.

Oscar Health shares rally on a bullish Barclays’ research note. Here’s how high the investment firm believes OSCR stock could fly in 2026.

Oracle (ORCL) reported fourth quarter results on Wednesday after the closing bell. Adjusted earnings per share (EPS) came in at $2.11 (compared to analyst estimates of $1.97), and adjusted revenue came in at $19.18 billion (compared to analyst estimates of $19.09 billion). Yahoo Finance's Josh Lipton takes a closer look at the breaking numbers.

Global stock markets mostly fell on Wednesday as fresh strikes in the Middle East, a jump in US inflation and a tech sell-off weighed on sentiment.While the headline figure jumped, the core reading that excludes energy prices that have surged due to war in the Middle East, held steady at 2.9 percent.

Mid-year is when income-focused investors tend to take a hard look at their portfolios. With the second half of 2026 ahead, retirees and near-retirees are leaning into reliable dividend payers that can keep checks coming through any summer volatility. The three names below combine long dividend histories, defensive cash flows, and recent raises, exactly the ... 3 Dividend Stocks Built for Retirement to Buy in June

Webull shares jumped as traders piled into call options. A recent rule change could mean more revenue for the retail broker.

NYSE veteran Peter Tuchman says disciplined retail traders could beat the S&P 500 as a new generation turns smart money.

As Mizuho predicts a $550 billion market for fast AI inference by 2030, Wall Street is rightly excited about Cerebras stock.

Patrick Moorhead says the AI buildout is still intact — and explains why now is the time to get in on the AI trade revealing the names he thinks are best positioned, including Dell, HP, Cisco, Qualcomm, Micron, and Intel.

Investing.com -- Pfizer shares may have found a more balanced risk-reward profile after a sharp decline this year, prompting RBC Capital Markets to upgrade the drugmaker to Sector Perform from Underperform while maintaining its $25 price target. The brokerage said the stock's roughly 11% pullback from its 2026 highs has brought valuation in line with its expectations, reducing the downside risks it had previously highlighted.

Investors question pricing power, tool adoption, and capacity growth despite ASML's central role in advanced chipmaking.

Investing.com -- Illumina received a bullish rating upgrade from JPMorgan, which raised its recommendation to Overweight from Neutral and lifted its December 2026 price target to $185 from $125, citing growing confidence in the DNA sequencing company's ability to sustain strong growth despite increasing competition.

New data center agreement highlights India's growing role in the AI infrastructure race.

Operating margin target raised to 30% and FCF margin lifted to 30%-35%, with GAAP profitability expected by 2028